BC
The startup develops automated proteomics technology for functional proteome analysis and targeted drug research, focusing on micro-clinical samples. This approach enables the discovery of new drug targets for the treatment of cancer and other critical illnesses, providing essential technical support to the medical industry.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops automated proteomics technology for functional proteome analysis and targeted drug research, focusing on micro-clinical samples. This approach enables the discovery of new drug targets for the treatment of cancer and other critical illnesses, providing essential technical support to the medical industry.